131 related articles for article (PubMed ID: 37608493)
1. OTUB1 inhibits breast cancer by non-canonically stabilizing CCN6.
Zhao Y; Ruan J; Li Z; Su X; Chen K; Lin Y; Cai Y; Wang P; Liu B; Schlüter D; Liang G; Wang X
Clin Transl Med; 2023 Aug; 13(8):e1385. PubMed ID: 37608493
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of OTU domain-containing ubiquitin aldehyde-binding protein 1 exacerbates colorectal cancer malignancy by inhibiting protein degradation of β-Catenin via Ubiquitin-proteasome pathway.
Ye D; Wang S; Wang X; Lin Y; Huang Y; Chi P
Bioengineered; 2022 Apr; 13(4):9106-9116. PubMed ID: 35354355
[TBL] [Abstract][Full Text] [Related]
3. The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells.
Huang W; Martin EE; Burman B; Gonzalez ME; Kleer CG
Oncotarget; 2016 May; 7(18):25180-93. PubMed ID: 26933820
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis.
Han X; Ren C; Lu C; Qiao P; Yang T; Yu Z
Cell Death Differ; 2022 Sep; 29(9):1864-1873. PubMed ID: 35296795
[TBL] [Abstract][Full Text] [Related]
5. OTUB1 augments hypoxia signaling via its non-canonical ubiquitination inhibition of HIF-1α during hypoxia adaptation.
Liu X; Deng H; Tang J; Wang Z; Zhu C; Cai X; Rong F; Chen X; Sun X; Jia S; Ouyang G; Li W; Xiao W
Cell Death Dis; 2022 Jun; 13(6):560. PubMed ID: 35732631
[TBL] [Abstract][Full Text] [Related]
6. Otubain 1: a non-canonical deubiquitinase with an emerging role in cancer.
Saldana M; VanderVorst K; Berg AL; Lee H; Carraway KL
Endocr Relat Cancer; 2019 Jan; 26(1):R1-R14. PubMed ID: 30400005
[TBL] [Abstract][Full Text] [Related]
7. OTUB1 overexpression in mesangial cells is a novel regulator in the pathogenesis of glomerulonephritis through the decrease of DCN level.
Zhang Y; Hu R; Wu H; Jiang W; Sun Y; Wang Y; Song Y; Jin T; Zhang H; Mao X; Zhao Z; Zhang Z
PLoS One; 2012; 7(1):e29654. PubMed ID: 22279542
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1.
Sun XX; Dai MS
World J Biol Chem; 2014 May; 5(2):75-84. PubMed ID: 24920999
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1.
Zhu D; Xu R; Huang X; Tang Z; Tian Y; Zhang J; Zheng X
Cell Death Differ; 2021 Jun; 28(6):1773-1789. PubMed ID: 33328570
[TBL] [Abstract][Full Text] [Related]
10. SET7 methylates the deubiquitinase OTUB1 at Lys
Deng H; Jia S; Tang J; Rong F; Xu C; Chen X; Wang Z; Zhu C; Sun X; Liao Q; Liu W; Li W; Xiao W; Liu X
J Biol Chem; 2023 Apr; 299(4):103054. PubMed ID: 36822329
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition and deubiquitination of cyclic K48-linked ubiquitin chains by OTUB1.
Sorada T; Morimoto D; Walinda E; Sugase K
Biochem Biophys Res Commun; 2021 Jul; 562():94-99. PubMed ID: 34049206
[TBL] [Abstract][Full Text] [Related]
12. CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer.
Pal A; Huang W; Li X; Toy KA; Nikolovska-Coleska Z; Kleer CG
Cancer Res; 2012 Sep; 72(18):4818-28. PubMed ID: 22805309
[TBL] [Abstract][Full Text] [Related]
13. Non-canonical deubiquitination of OTUB1 induces IFNγ-mediated cell cycle arrest via regulation of p27 stability.
Lee SG; Woo SM; Seo SU; Lee HS; Kim SH; Chang YC; Cho HJ; Yook S; Nam JO; Kwon TK
Oncogene; 2024 Jun; 43(24):1852-1860. PubMed ID: 38664499
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinating enzyme OTUB1 in immunity and cancer: Good player or bad actor?
Liao Y; Yang M; Wang K; Wang Y; Zhong B; Jiang N
Cancer Lett; 2022 Feb; 526():248-258. PubMed ID: 34875341
[TBL] [Abstract][Full Text] [Related]
15. OTUB1 Is a Key Regulator of RIG-I-Dependent Immune Signaling and Is Targeted for Proteasomal Degradation by Influenza A NS1.
Jahan AS; Biquand E; Muñoz-Moreno R; Le Quang A; Mok CK; Wong HH; Teo QW; Valkenburg SA; Chin AWH; Man Poon LL; Te Velthuis A; García-Sastre A; Demeret C; Sanyal S
Cell Rep; 2020 Feb; 30(5):1570-1584.e6. PubMed ID: 32023470
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Cross-Regulation by Different OTUB1:E2 Complexes.
Que LT; Morrow ME; Wolberger C
Biochemistry; 2020 Mar; 59(8):921-932. PubMed ID: 32049508
[TBL] [Abstract][Full Text] [Related]
17. The Deubiquitylase Otub1 Regulates the Chemotactic Response of Splenic B Cells by Modulating the Stability of the γ-Subunit Gng2.
Luo VM; Shen C; Worme S; Bhagrath A; Simo-Cheyou E; Findlay S; Hébert S; Wai Lam Poon W; Aryanpour Z; Zhang T; Zahedi RP; Boulais J; Buchwald ZS; Borchers CH; Côté JF; Kleinman CL; Mandl JN; Orthwein A
Mol Cell Biol; 2024 Jan; 44(1):1-16. PubMed ID: 38270191
[TBL] [Abstract][Full Text] [Related]
18. CCN6-mediated MMP-9 activation enhances metastatic potential of human chondrosarcoma.
Tzeng HE; Tang CH; Wu SH; Chen HT; Fong YC; Lu YC; Chen WC; Huang HD; Lin CY; Wang SW
Cell Death Dis; 2018 Sep; 9(10):955. PubMed ID: 30237403
[TBL] [Abstract][Full Text] [Related]
19. Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo.
Wang P; Joberty G; Buist A; Vanoosthuyse A; Stancu IC; Vasconcelos B; Pierrot N; Faelth-Savitski M; Kienlen-Campard P; Octave JN; Bantscheff M; Drewes G; Moechars D; Dewachter I
Acta Neuropathol; 2017 May; 133(5):731-749. PubMed ID: 28083634
[TBL] [Abstract][Full Text] [Related]
20. CCN6 knockdown disrupts acinar organization of breast cells in three-dimensional cultures through up-regulation of type III TGF-β receptor.
Pal A; Huang W; Toy KA; Kleer CG
Neoplasia; 2012 Nov; 14(11):1067-74. PubMed ID: 23226100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
